After Wegovy and Zepbound, 6 weight-loss drugs in development

After Wegovy and Zepbound, 6 weight-loss drugs in development
New weight-loss drugs from Novo Nordisk, Eli Lilly, Pfizer, Roche, Amgen and Viking Therapeutics offer a look at where obesity treatment could go after Wegovy and Zepbound

Take Your Experience to the Next Level

New

Download our mobile app for a faster and better experience.

Google Play
App Store

Comments

0
U

Join the discussion

Sign in to leave a comment

0:000:00